Lower Back Pain
1
Pipeline Programs
4
Companies
3
Clinical Trials
2 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
3 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
2027
Centrexion TherapeuticsCNTX-3001
SPR TherapeuticsSPRINT PNS System
Spine BioPharmaDiagnostic
Clinical Trials (3)
Total enrollment: 126 patients across 3 trials
Safety and PK of Intrathecal CNTX-3001 for Intractable Chronic Low Back Pain
Start: Mar 2026Est. completion: Jan 202716 patients
Phase 1Recruiting
Peripheral Nerve Stimulation With the SPRINT® System in Chronic PSIJC Pain
Start: Oct 2025Est. completion: Oct 202710 patients
N/ARecruiting
Comparison of Electronic Calipers to Conventional Calipers and X-ray Measurement of Spinal Tilt
Start: Oct 2016Est. completion: Nov 2017100 patients
N/AUnknown
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
2 actively recruiting trials targeting 126 patients
4 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.